Clinical trial
A 24-month Prospective, Non-interventional, International, Multicentre Study to Describe the Real-world Effectiveness and Usage of Alprolix in Patients With Haemophilia B
NCT03901755 is registered in ClinicalTrials.gov with Swedish Orphan Biovitrum as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A 24-month Prospective, Non-interventional, International, Multicentre Study to Describe the Real-world Effectiveness and Usage of Alprolix in Patients With Haemophilia B
- Lead sponsor
- Swedish Orphan Biovitrum
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 12, 2019
- Completion date
- March 12, 2024
- Enrollment
- 151 (actual)
- Sites
- 29
Conditions
As the registry lists them; a condition with its own page is linked.